Enovix (ENVX) Cash & Equivalents (2020 - 2026)

Enovix (ENVX) has 7 years of Cash & Equivalents data on file, last reported at $88.8 million in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 53.26% year-over-year to $88.8 million; the trailing twelve-month figure through Apr 2026 stood at $88.8 million (down 53.26% YoY), and the FY2025 full-year result was $106.0 million, down 61.15% from the prior year.
• Cash & Equivalents for Q2 2026 stood at $88.8 million, down from $106.0 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $408.2 million in Q2 2022 and bottomed at $88.8 million in Q2 2026.
• The 5-year median for Cash & Equivalents is $271.8 million (2023), against an average of $265.4 million.
• The widest annual swing landed in 2022, when Cash & Equivalents soared 7670.75%; it then tumbled 61.15% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $349.0 million in 2022, then tumbled by 33.2% to $233.1 million in 2023, then grew by 17.05% to $272.9 million in 2024, then sank by 61.15% to $106.0 million in 2025, then declined by 16.28% to $88.8 million in 2026.
• The last three Cash & Equivalents figures came in at $88.8 million (Q2 2026), $106.0 million (Q4 2025), and $335.5 million (Q3 2025), per Business Quant data.

Peer Comparison